Basic science for the clinician 43: The mitogen-activated protein kinase family in inflammatory signaling

Journal of Clinical Rheumatology

Volumn 13, Issue 2, 2007, Pages 96-99

  Sigal, Leonard H ^a,b  

^a BRISTOL MYERS SQUIBB   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

ERK; JNK; MAPKK; MAPKKK; MEK; MEKK; Mitogen activated protein kinase; p38 MAP kinase

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; FETUS GROWTH; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; MOLECULAR BIOLOGY; NONHUMAN; OSTEOARTHRITIS; OSTEOCLAST; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

HUMANS; INFLAMMATION; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 34247115988     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000260657.59520.48     Document Type: Article

References (0)